Concepedia

Eva Diana Runkel

ED

6

Publications

336

Citations

6

H-Index

2013

Active since

Affiliations

University Hospital Schleswig-Holstein(Current)

University Hospital Cologne

Hospital Universitario de La Princesa

Palmerston North Hospital

University Hospital Ulm

Eva Diana Runkel is an author at University Hospital Schleswig-Holstein specializing in medicine, pathology, and cancer research.

Top concepts

MedicinePathologyCancer ResearchHealthOncologyHematologyImmunologyImmunotherapyClinical TrialsImmune Surveillance

Publications per year

2013–2024

6

Publications

6

Surveillance-Activated Defenses Block the ROS–Induced Mitochondrial Unfolded Protein Response

Eva Diana Runkel, Shu Liu, Ralf Baumeister et al. · PLoS Genetics · 2013 · 180 citations · Full text

Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study

Othman Al‐Sawaf, Sandra Robrecht, Can Zhang et al. · Blood · 2024 · 92 citations · Full text

Genetic overlap between dystonia and other neurologic disorders: A study of 1,100 exomes

Ivana Dzinovic, Sylvia Boesch, Matěj Škorvánek et al. · Parkinsonism & Related Disorders · 2022 · 21 citations

Neurodegenerative Diseases, Mendelian Disorder, Genetic Overlap +10

S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY

Othman Al‐Sawaf, Sandra Robrecht, Can Zhang et al. · HemaSphere · 2023 · 18 citations · Full text

Chronic Lymphocytic Leukemia, Mixed-phenotype Acute Leukemia, Immunology +16

VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY

Othman Al‐Sawaf, Sandra Robrecht, C. Zhang et al. · Hematological Oncology · 2023 · 13 citations · Full text

Immunology, Pathology, Immunotherapy +16

Rows per page

1–5 of 6